Company Sangui Biotech International, Inc. Other OTC
Equities
SGBI
US80105B1017
Biotechnology & Medical Research
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Thomas Striepe
CEO | Chief Executive Officer | 62 | 07/05/07 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Thomas Striepe
CEO | Chief Executive Officer | 62 | 07/05/07 |
Hubertus Schmelz
BRD | Director/Board Member | 68 | 18/08/18 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 209,955,598 | 182,538,524 ( 86.94 %) | 53,756 ( 0.0256 %) | 86.94 % |
Company contact information
Sangui BioTech International, Inc.
Bleichenbruecke 9
20354, Hamburg
+49 40 609 3120
http://www.sanguibiotech.com![address Sangui Biotech International, Inc.(SGBI)](https://cdn.zonebourse.com/static/address/408487.png)
Sector
1st Jan change | Capi. | |
---|---|---|
+18.47% | 44.87B | |
-10.10% | 37.8B | |
+39.84% | 37.61B | |
+29.30% | 31.32B | |
-8.44% | 27.4B | |
+12.52% | 26.32B | |
+42.93% | 14.07B | |
+31.55% | 12.5B | |
-6.10% | 11.23B |